Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases

Intravitreal triamcinolone acetonide may offer a possibility for adjunctive treatment of intraocular edematous and neovascular disorders. One has to take into account the side-effects and the lack of long-term follow-up observations.